ViroPharma 2Q net income jumps on Cinryze sales
(AP:EXTON, Pa.) ViroPharma Inc. said Wednesday its second-quarter net income rose 78 percent on higher sales of the company’s hereditary disorder drug Cinryze.
Read more on INO News
Popular Posts:
- Medicines Co. jumps on Angiomax patent hopes
- VCA Antech 2Q net income rises slightly
- VCA Antech 2Q net income rises slightly
- University Medical Center board lays groundwork for bond sales
- How does Medicaid income eligibility work when your pay goes up and down?